Janus Henderson Group
ACHN

Janus Henderson Group’s Achillion Pharmaceuticals ACHN Stock Holding History

Janus Henderson Group’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,097,765
Closed -$4.04M – 1460
2018
Q3 		$4.04M Hold
1,097,765
– – ﹤0.01% 1063
2018
Q2 		$3.11M Hold
1,097,765
– – ﹤0.01% 1092
2018
Q1 		$4.07M Buy
1,097,765
+94,018
+9% +$308K ﹤0.01% 1050
2017
Q4 		$2.89M Sell
1,003,747
-2,872,962
-74% -$10.4M ﹤0.01% 1070
2017
Q3 		$17.4M Sell
3,876,709
-650,108
-14% -$2.89M 0.01% 762
2017
Q2 		$20.8M Buy
+4,526,817
New +$18.2M 0.01% 732

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Janus Henderson Group's ACHN Position: Q4 2018 in Review

Janus Henderson Group sold out of Achillion Pharmaceuticals (ACHN) in Q4 2018, closing a stake of 1,097,765 shares — an estimated $4.04M sold.

Janus Henderson Group first reported a position in ACHN in Q2 2017 and held it in 6 quarters. The position peaked at $20.8M in Q2 2017. 121 funds tracked by Wall St. Rank hold ACHN as of Q4 2018.

  • Janus Henderson Group reported no remaining Achillion Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Janus Henderson Group sold 1,097,765 Achillion Pharmaceuticals shares in Q4 2018, an estimated $4.04M.
  • Janus Henderson Group first reported a position in Achillion Pharmaceuticals in Q2 2017 and held it in 6 quarters.
  • Janus Henderson Group's Achillion Pharmaceuticals position peaked at $20.8M in Q2 2017.
  • 121 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2018.

Based on Janus Henderson Group's 13F filing for Q4 2018, filed 6 Feb 2019.